Promoter collection, Human VEGFA promoter
Alternative name | U2749(2127)-8 |
---|---|
Clone info. | PCR amplified human VEGFA promoter sequence was inserted into a firefly luciferase vector. Cloned fragment: 43769068 to 43770372(NC_000006.12); relatively -1141 to +164, where +1 corresponds to 1 nt of NM_001025366.2. |
Comment | PCR cloning, forward primer: 5’- GGCGGGTAGGTTTGAATCAT -3’; reverse primer : 5’- AGGGATAAAACCCGGATCAA -3’. Entire sequence of promoter region has not been confirmed. |
Vector backbone | pGL4.10 [Luc2] (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human vascular endothelial growth factor A genomic DNA |
Depositor|Developer | DNA Bank, | Kishikawa, Shotaro | |
Remarks, protocol and/or map (pdf) | RDB07681.pdf |
---|
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. Additional terms and conditions: The use of the BIOLOGICAL RESOURCE is restricted to the academic researches conducted by non-profit organization. By using this material, the RECIPIENT agrees to be bound by the conditions of the limited use statement of the Promega Corporation. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 謝辞の表明を必要とする。 MTAに書く付加的使用条件: 本件リソースの使用は学術機関での学術研究に限る。本件リソースの使用にあたって、利用者はプロメガ社の限定使用条件に従う必要がある。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB07681 | pGL4-phVEGFA | DNA solution |
Materials & Methods section:
The pGL4-phVEGFA was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07681). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB07681_A4Am.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: Sequence file: RDB07681_A4Ama.seq |
---|
>07681_07681_A4Am_pGL4-4174F_C10_07.ab1 1 AAGGGGCCAG GAAAATTTTC TCTGGCCTAA CTGGCCGGTA CCTGAGCTCG CTAGCCTCGA 61 GGATGGCGGG TAGGTTTGAA TCATCACGCA GGCCCTGGCC TCCACCCACC CCCACCAGCC 121 CCCTGGCCTC AGTTCCCTGG CAACATCTGG GGTTGGGGGG GCAGCAGGAA CAAGGGCCTC 181 TGTCTGCCCA GCTGCCTCCC CCTTTGGGTT TTGCCAGACT CCACAGTGCA TACGTGGGCT 241 CCAACAGGTC CTCTTCCCTC CCAGTCACTG ACTAACCCCG GAACCACACA GCTTCCCGTT 301 CTCAGCTCCA CAAACTTGGT GCCAAATTCT TCTCCCCTGG GAAGCATCCC TGGACACTTC 361 CCAAAGGACC CCAGTCACTC CAGCCTGTTG GCTGCCGCTC ACTTTGATGT CTGCAGGCCA 421 AATGAGGGCT CCAGATGGCA CATTGTCAGA GGGACACACT GTGGCCCCTG TGCCCAGCCC 481 TGGGCTCTCT GTACATGAAG CAACTCCAGT CCCAAATATG TAGCTGTTTG GGAGGTCAGA 541 AATAGGGGGT CCAGGAGCAA ACTCCCCCCA CCCCCTTTCC AAAGCCCATT CCCTCTTTAG 601 CCAGAGCCGG GGTGTGCAGA CGGCAGTCAC TAGGGGGCGC TCGGCCACCA CAGGGAAGCT 661 GGGTGAATGG AGCGAGCAGC GTCTTCGAGA GTGAGGACGT GTGTGTCTGT GTGGGTGAGT 721 GAGTGTGTGC GTGTGGGGTT GAGGGTGTTG GAGCGGGCGT ATGCCCTGTG GTGA // |
Primer: Sequence file: RDB07681_A4Amb.seq |
>07681_07681_A4Am_pGL4-136R_D10_10.ab1 1 GGCCTAAAGT TTTTTTGGCA TCTTCCATGG TGGCTTTACC AACAGTACCG GATTGCCAAG 61 CTTGGCCGCC GAGGCCAGAT CTTGATAGGG ATAAAACCCG GATCAATGAA TATCAAATTC 121 CAGCACCGAG CGCCCTGGCC GGTGAGTCCG CTGACCGGTC CACCTAACCG CTGCGCCTCC 181 CGACAGAGCG CTGGTGCTAG CCCCCAGCGC CACGACCTCC GAGCTACCCG GCTGCCCCAA 241 GCCTCCGCGA TCCTCCCCGC TACCAGCCGA CTTTTAAAAA AAAAAGGGGG GGGCGCATGG 301 CTCCGCCCCG CCGGGACCCC GCCCCCGGCC CGCCCCGGGG GGCGGGGACA GGCGAGCCTC 361 AGCCCCTCCA CACGCGGCTC GGGCCCGGGC TCTGCGGACG CCCAGTGAAG CCTGGCCCGC 421 AGCCCGCCGC AATGAAGGGG AAGCTCGACC CCCACCAAGG TTCACAGCCT GAAAATTACC 481 CATCCGCCCC CGGAAACTCT GTCCAGAGAC ACGCGCCCGC GGGGCATTGG CGAGGAGGGA 541 GCAGGAAAGT GAGGTTACGT GCGGACAGGG CCTGAGAGCC GTTCCCTCTT TGCTAGGAAT 601 ATTGAAGGGG GCAGGGGAAG GCGGAGAGCC GGACAGGGAC GGGTGGGGAG AGGGACACAC 661 AGATCTATTG GAATCCTGGA GTGACCCCTG GCCTTCTCCC CGCTCCAACA CCCTCAACCC 721 CACACGCACA CACTCACTCA CCCACACAGA CACACACGTC CTCACTCTCG AAGACGCTGC 781 TCGCTCCATT CACCCAGCTT CCCTGTGGTG GCCGAGCGCC CCCTAGTGAC TGCCGTCTGC 841 ACACCCCGGC TCTGGCTAAA GAGGGAATGG GCTTTGGAAA GGGGGTGGGG GGAGTTTGCT 901 CCTGGACCCC CTATTTCTGA CCTCCCAAAC AGCTACATAT TTGGGACTGG AGTTGCTTCA 961 TGTACAGAGA GCCCAGGGCT GGGCACAGGG GCCACAGTGT GTCCCTCTGA CAATGTGCCA 1021 TCTGGAGCCC TCATTTGGCC CTGCAGACAT CAAAGTGAGC GGCAGGCCAA CAAGCTGGAG 1081 TGACTGGGTC CTTTGGGAAG TGTCCAGGAT GCTTCCCAAG GAGAGAATTG CACCAGGTTG 1141 TTGAGCTGGA GAAACCGGGA AGGT // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
user_report | Hasan, A.U., Eicosapentaenoic acid upregulates VEGF-A through both GPR120 and PPARγ mediated pathways in 3T3-L1 adipocytes. Mol. Cell. Endocrinol. 406:10-18 (2015). PMID 25697344. [link to RRC of NBRP] |
---|
Featured content